No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
XFIN EXCELFIN ACQUISITION CORP
- 11.090
- +0.090+0.82%
Close Apr 24 16:00 ET
88.18MMarket Cap-50409P/E (TTM)
11.100High11.090Low1.18KVolume11.000Open11.000Pre Close13.08KTurnover0.02%Turnover RatioLossP/E (Static)7.95MShares11.10052wk High7.24P/B88.18MFloat Cap10.24052wk Low--Dividend TTM7.95MShs Float11.100Historical High--Div YieldTTM0.09%Amplitude9.670Historical Low11.095Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | ExcelFin Acquisition Corp. Announces Increase in Extension Payment
Express News | ExcelFin Acquisition Corp. Announces 30-Day Extension of Extension Proposal
ExcelFin Acquisition, Baird: Updated Transaction Terms in Part Driven by Baird Medical's Lower Than Expected 2023 Results
ExcelFin Acquisition, Baird: Updated Transaction Terms in Part Driven by Baird Medical's Lower Than Expected 2023 Results
Baird Medical Agreed to Subject 30% of Its Shrs to Be Received in Transaction to Earnout at $12.50 Trading Price
Baird Medical Agreed to Subject 30% of Its Shrs to Be Received in Transaction to Earnout at $12.50 Trading Price
Baird Medical Is Expected to Trade on Nasdaq Under Ticker BDMD Upon Closing
Baird Medical Is Expected to Trade on Nasdaq Under Ticker BDMD Upon Closing
ExcelFin Acquisition, Baird: Minimum Cash Condition of $15 M Has Been Waived >XFIN
ExcelFin Acquisition, Baird: Minimum Cash Condition of $15 M Has Been Waived >XFIN
Comments
News
$EXCELFIN ACQUISITION CORP(XFIN.US$ ExcelFin Acquisition Merger Partner Baird Medical Devices Subsidiary, Betters (Suzhou) Medical Has Received FDA Clearance To Begin Marketing Its Microwave Ablation Systems In The U.S
1
9
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
JESSE JAMES8832 : hmmm nice find i like this one looks like a good value stock
TrytosaveabitOP JESSE JAMES8832: Thanks! I think so also at least what I’m finding so far. I believe it’s going to be more of a bit longer hold than I usually do? But yeah I’m kinda digging it! GL hope you have a killer day my man
JESSE JAMES8832 : only thing i see is that if you compare it too alot in its class they dont seem to climb much higher than 11 i guess.!?
TrytosaveabitOP JESSE JAMES8832: Yeah! But I’m hoping as the news of the availability of this new thyroid treatment gets out that they will start selling the hell out of it! It’s pretty amazing how they now can treat thyroid disease and still be able to save the thyroid! That should be pretty big?
TrytosaveabitOP JESSE JAMES8832: Oh and it looks like from what I’m seeing so far. They still have to complete the merger? The business combination was extended again, they now have at the latest April? But now I think that will happen quicker? Then that’s when I believe it could really get interesting? JMO though! Hehehe
View more comments...